Possible scenario
Fragmented Global Response
20% Chance
Regulators outside the United States move at different speeds, creating a patchwork of bio-AI compliance obligations. This is realistic because the EU, UK, China, and US have different priorities around frontier AI, synthetic biology, public health, and national security.
Secondary impacts
- Healthcare -0.9%
- Technology -0.9%
- Business Services +0.3%
Tickers
- RXRX-2.4%
- DNA+1.5%
- SDGR-0.8%
- -0.5%
Portfolio impact
S&P 500-0.5%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.